[1] |
WANG Yaya, CHU Zixuan, YANG Junling, Olajide E. Olaleye, HE Rongrong, LI Muzi, CHENG Chen, LI Chuan.
Potential health benefits of resveratrol: a pharmacokinetics-caused conundrum
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 931-954.
|
[2] |
JIN Le, JIANG Duochen, CHEN Hongxiao, LIU Su, CHEN Zhaolin, JU Jing.
Quercetin reverses adriamycin resistance by activating GSK-3β/β-catenin pathways through GAS5 in breast cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1344-1351.
|
[3] |
PAN Zhanhe, WANG Xin, SU An, ZHANG Peng, JI Haonan, WANG Xiaomei.
Mechanism of celecoxib reverses adriamycin resistance in NK/T cell lymphoma cells by Notch 1/NF-κB/STAT3 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1330-1336.
|
[4] |
SHAO Feng, SUN Jian-guo, WANG Guang-ji.
Toxicokinetics of triptolide in Beagle dogs after oral and intravenous administration
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1326-1331.
|
[5] |
SHEN Qun-shan, HUANG Hou-bao, PAN Cai-ming, XUE Jun, CAI Zhang-yu, WANG Xiao, JIANG Shu-chuan.
Prevention effect of 4-HPR on bladder tumor in SD rats: An in vivo experiment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 972-977.
|
[6] |
YANG Yan-lang1,2, ZOU He-qun1, ZHANG Dao-you2, WANG Yu-wei2, LI Fan-xia2, GAO Chao-qing2, XU Hai-hong2, CHENG Xiao-mei2.
Renal tubular protection effect of combining benazepril and spironolactone in adriamycin-induced nephritic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(4): 381-386.
|
[7] |
ZHAO Wen-ying, CHEN Dong-yun, XING Wen, WU Ming , YANG Zhi-min, JI Zhao-ning.
Primary exploration on the protective effect of phosphocreatine sodium on adriamycin-induced cardiotoxicity in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 259-262.
|
[8] |
CHEN Ji-hong, ZHOU Dong, GAO Kun, HE Wei-ming,WANG Yue-juan, SUN Wei.
Expression of NF-κB and IκB in rats with adriamycin nephropathy and the role of Dahuangzhechong Wan
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(1): 22-26.
|
[9] |
LIU Yi-ming, LIN Ai-hua, DENG Shi-gui, WU Zhi-feng, OU Run-mei.
Tissue distribution of adriamycin-loaded chitosan nanoparticles surface-modified with glycyrrhizin in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(1): 66-71.
|
[10] |
YANG Yan-lang, ZHANG Dao-you, WANG Xiang-ming, CUI Ming-chun, WU Xiao-dong.
Renoprotective effect and mechanisms of benazepril and pentifylline on adriamycin nephropathy rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 736-740.
|
[11] |
QIU Qiao-meng, LIANG Huan, HONG Guang-liang, LU Zhong-qiu, LIU Gang, WANG Zhi-yi.
Study on toxicokinetics in wild aconite poisoned rabbits after hemoperfusion
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(5): 551-556.
|
[12] |
YAO Rong-xin, FENG Liang-hua, XIA Yi-zi, ZHU Bao-ling.
Study on protection and mechanism for adriamycin-induced cardiotoxicity with tiopronin in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1216-1220.
|
[13] |
YANG Jing-ya, WANG Xiao-ji, ZHANG Jian.
Antitumor effect of combination of carboxymethyl-chitosan and Adriamycin in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1253-1257.
|
[14] |
XU Xiao-yue, JIANG Zhen-zhou, HUANG Xin, ZHANG Lu-yong.
Determination of aristolochic acid Ⅰ in rats by HPLC and its toxicokinetics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(2): 144-148.
|
[15] |
LIU Hong-zhi, GAO Chuan-yu, LEI Jian, LUO Bing, LI Zuo-min, ZHOU Jun,HE Li-qun, QI Ben-ling, CAO Lin-sheng.
Experimental study on rosiglitazone reversing myocardial interstitial fibrosis of rats with heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(8): 896-899.
|